Search

Your search keyword '"Ban, T"' showing total 38 results
Start Over Author "Ban, T" Topic tranquilizing agents
38 results on '"Ban, T"'

2. Pharmacotherapy of schizophrenia.

Author

Ban TA

Subjects
Chemical Phenomena, Chemistry, Corpus Striatum drug effects, Corpus Striatum metabolism, Dopamine metabolism, Dyskinesia, Drug-Induced etiology, Eye Diseases chemically induced, Humans, Limbic System drug effects, Pigmentation Disorders chemically induced, Receptors, Dopamine drug effects, Tranquilizing Agents adverse effects, Tranquilizing Agents pharmacology, Schizophrenia drug therapy, Tranquilizing Agents therapeutic use
Published
1976

3. Clomacran in the treatment of schizophrenic patients: a comparison of two assessment methods.

Author

Pecknold JC, Ban TA, Lehmann HE, and Climan M

Subjects
Acridines adverse effects, Adolescent, Adult, Chlorpromazine analogs & derivatives, Clinical Trials as Topic, Electroencephalography, Female, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Tranquilizing Agents adverse effects, Acridines therapeutic use, Schizophrenia drug therapy, Tranquilizing Agents therapeutic use
Abstract

In an uncontrolled clinical trial clomacran, the chlorpromazine analogue of the acridane series, was found to be therapeutically effective in the treatment of newly admitted schizophrenic patients. There was essentially no difference in the sensitivity of the two assessment instruments, i.e. BPRS and PAF, in the detection of therapeutic changes. On the other hand, the PAF, a 123-item scale, was found to be more sensitive for the description of a schizophrenic patient population than the BPRS, an 18-item scale.

Published
1975

4. A transcultural study with clomacran: comparison of two assessment methods.

Author

Ban TA, Lehmann HE, Galvan L, Pecknold JC, and Climan M

Subjects
Adolescent, Adult, Canada, Chlorpromazine, Clinical Trials as Topic, Drug Evaluation, Female, Humans, Male, Mexico, Middle Aged, Pilot Projects, Placebos, Propylamines therapeutic use, Psychiatric Status Rating Scales, Time Factors, Acridines therapeutic use, Cross-Cultural Comparison, Schizophrenia drug therapy, Tranquilizing Agents therapeutic use
Published
1974

5. Trazodone in the treatment of schizophrenias.

Author

Galvan L, Nair NP, Kussin D, and Ban TA

Subjects
Antidepressive Agents administration & dosage, Chronic Disease, Clinical Trials as Topic, Female, Humans, Male, Middle Aged, Piperazines administration & dosage, Piperazines adverse effects, Placebos, Psychiatric Status Rating Scales, Pyridines administration & dosage, Pyridines adverse effects, Time Factors, Tranquilizing Agents administration & dosage, Triazoles administration & dosage, Triazoles adverse effects, Triazoles therapeutic use, Antidepressive Agents therapeutic use, Piperazines therapeutic use, Pyridines therapeutic use, Schizophrenia drug therapy, Tranquilizing Agents therapeutic use
Published
1973

6. Studies with new drugs in the treatment of convulsive disorders.

Author

Lehmann HE and Ban TA

Subjects
Adult, Aggression, Anxiety, Carbamazepine therapeutic use, Clinical Trials as Topic, Epilepsy complications, Frustration, Hallucinations, Humans, Intellectual Disability, Middle Aged, Object Attachment, Perceptual Disorders, Psychiatric Status Rating Scales, Psychopathology, Schizophrenia, Anticonvulsants therapeutic use, Diazepam therapeutic use, Dibenzazepines therapeutic use, Epilepsy drug therapy, Nitriles therapeutic use, Phenothiazines therapeutic use, Piperidines therapeutic use, Thiazines therapeutic use, Tranquilizing Agents therapeutic use
Published
1968

8. Lack of indication for use of antiparkinson medication. A follow-up study.

Author

Pecknold JC, Ananth JV, Ban TA, and Lehmann HE

Subjects
Adolescent, Adult, Female, Follow-Up Studies, Humans, Intellectual Disability drug therapy, Male, Middle Aged, Nortropanes therapeutic use, Parasympatholytics administration & dosage, Parkinson Disease prevention & control, Parkinson Disease, Secondary chemically induced, Procyclidine therapeutic use, Schizophrenia drug therapy, Substance Withdrawal Syndrome, Sulfonic Acids therapeutic use, Time Factors, Tranquilizing Agents therapeutic use, Trihexyphenidyl therapeutic use, Mental Disorders drug therapy, Parasympatholytics therapeutic use, Tranquilizing Agents adverse effects
Published
1971

9. The neuroleptics. 8. Clinical methodology.

Author

Ban TA, Bordeleau JM, Debray HR, Hamilton M, Ito H, Overall JE, Pichot P, Reda G, Tetreault L, Volmat R, and Wiart C

Subjects
Clinical Trials as Topic, Ethics, Professional, Humans, Mental Disorders classification, Placebos, Psychiatric Status Rating Scales, Research, Research Design, Statistics as Topic, Mental Disorders drug therapy, Tranquilizing Agents therapeutic use
Published
1970

10. The place of thiothixene among the thioxanthenes.

Author

Sterlin C, Ban TA, and Jarrold L

Subjects
Acute Disease, Adolescent, Adult, Central Nervous System drug effects, Chlorprothixene adverse effects, Chlorprothixene therapeutic use, Chronic Disease, Clinical Trials as Topic, Clopenthixol adverse effects, Clopenthixol therapeutic use, Evaluation Studies as Topic, Female, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Schizophrenia drug therapy, Thiothixene adverse effects, Thiothixene therapeutic use, Tranquilizing Agents therapeutic use, Xanthenes therapeutic use
Published
1972

11. Pharmacotherapy of tension and anxiety.

Author

Lehmann HE and Ban TA

Subjects
Automobile Driving, Carbamates therapeutic use, Cerebral Cortex drug effects, Clinical Trials as Topic, Depression drug therapy, Dibenzoxepins therapeutic use, Evaluation Studies as Topic, Humans, Hydroxyzine therapeutic use, Neurotic Disorders drug therapy, Nitrazepam therapeutic use, Placebos, Propylene Glycols therapeutic use, Sleep Initiation and Maintenance Disorders drug therapy, Suicide, Tranquilizing Agents pharmacology, Anxiety drug therapy, Stress, Psychological drug therapy, Tranquilizing Agents therapeutic use
Published
1972

12. [Propericiazine in the control of anti-social behavior].

Author

Roy PB, Ferguson K, St Jean A, Lee H, and Ban TA

Subjects
Adult, Humans, Male, Antisocial Personality Disorder, Intellectual Disability complications, Phenothiazines therapeutic use, Tranquilizing Agents therapeutic use
Published
1966

13. NOTES FROM THE LOG-BOOK OF A PSYCHOPHARMACOLOGICAL RESEARCH UNIT I.

Author

LEHMANN HE and BAN TA

Subjects
Humans, Amobarbital, Behavior, Books, Chlordiazepoxide, Depression, Dextroamphetamine, Electroconvulsive Therapy, Fluphenazine, Haloperidol, Hyperthermia, Induced, Hypnotics and Sedatives, Lysergic Acid Diethylamide, Phenothiazines, Promazine, Psychopharmacology, Research, Speech Disorders, Thioridazine, Toxicology, Tranquilizing Agents
Published
1964
Full Text
View/download PDF

14. Clinical trial with cyclopentimine.

Author

SCHWARZ L, BAN T, and SMITH R

Subjects
Humans, Counseling, Electroconvulsive Therapy, Mental Disorders therapy, Piperidines therapy, Psychotherapy, Tranquilizing Agents therapy
Published
1961
Full Text
View/download PDF

15. Drug treatment in schizophrenia.

Author

Ban TA

Subjects
Butyrophenones therapeutic use, Chlorpromazine therapeutic use, Evaluation Studies as Topic, Humans, Phenylalanine metabolism, Reserpine therapeutic use, Schizophrenia metabolism, Thiothixene therapeutic use, Tryptophan metabolism, Phenothiazines therapeutic use, Schizophrenia drug therapy, Tranquilizing Agents therapeutic use, Xanthenes therapeutic use
Published
1971
Full Text
View/download PDF

16. Prazepam in the treatment of psychoneurotic outpatients: a brief report.

Author

Silver D, Ban TA, Kristof FE, Saxena BM, and Bennett J

Subjects
Adult, Chlordiazepoxide therapeutic use, Clinical Trials as Topic, Female, Humans, Male, Middle Aged, Placebos, Benzazepines therapeutic use, Neurotic Disorders drug therapy, Tranquilizing Agents therapeutic use
Published
1969

18. Clinical pharmacology of psychotropic drugs.

Author

Ban TA

Subjects
Animals, Behavior drug effects, Chlordiazepoxide pharmacology, Diazepam pharmacology, Humans, Neurotic Disorders drug therapy, Oxazepam pharmacology, Oxazepam therapeutic use, Tranquilizing Agents pharmacology, Tranquilizing Agents therapeutic use
Published
1967

19. Predictors of therapeutic responsivity to thiothixene in schizophrenics.

Author

Sterlin C, Oliveros R, and Ban TA

Subjects
Affective Symptoms drug therapy, Clinical Trials as Topic, Delusions drug therapy, Extrapyramidal Tracts, Hallucinations drug therapy, Humans, Movement Disorders chemically induced, Psychiatric Status Rating Scales, Tranquilizing Agents adverse effects, Schizophrenia drug therapy, Tranquilizing Agents therapeutic use
Published
1968

20. Propericiazine in psychiatric emergencies. A controlled comparative study.

Author

Ananth JV, Salib M, Ban TA, and Lehmann HE

Subjects
Acute Disease, Adolescent, Adult, Aggression drug effects, Clinical Trials as Topic, Emotions drug effects, Evaluation Studies as Topic, Female, Humans, Injections, Intramuscular, Male, Middle Aged, Neurotic Disorders drug therapy, Phenothiazines adverse effects, Psychotic Disorders drug therapy, Chlorpromazine therapeutic use, Mental Disorders drug therapy, Nitriles therapeutic use, Phenothiazines therapeutic use, Piperidines therapeutic use, Tranquilizing Agents therapeutic use
Published
1972
Full Text
View/download PDF

21. Mesoridazine in acute psychotic disturbances.

Author

Ast H, Amin M, Saxena BM, Lehmann HE, and Ban TA

Subjects
Adult, Female, Humans, Male, Middle Aged, Schizophrenia drug therapy, Phenothiazines therapeutic use, Psychotic Disorders drug therapy, Tranquilizing Agents therapeutic use
Published
1967

23. Fluspirilene in the treatment of chronic schizophrenic patients.

Author

Chouinard G, Ban TA, Lehmann HE, and Ananth JV

Subjects
Adult, Benzene Derivatives adverse effects, Benzene Derivatives therapeutic use, Female, Humans, Male, Middle Aged, Piperidines adverse effects, Spiro Compounds adverse effects, Spiro Compounds therapeutic use, Tranquilizing Agents adverse effects, Piperidines therapeutic use, Schizophrenia drug therapy, Tranquilizing Agents therapeutic use
Published
1970

26. Effects of psychoactive drugs on conflict avoidance behavior in human subjects.

Author

Lehmann HE and Ban TA

Subjects
Adolescent, Adult, Child, Chlordiazepoxide pharmacology, Chlorpromazine pharmacology, Electroshock, Female, Haloperidol pharmacology, Humans, Male, Meprobamate pharmacology, Neurotic Disorders drug therapy, Perphenazine pharmacology, Placebos, Amobarbital pharmacology, Avoidance Learning drug effects, Caffeine pharmacology, Conflict, Psychological, Methamphetamine pharmacology, Pentylenetetrazole pharmacology, Tranquilizing Agents pharmacology
Published
1971

30. An adverse reaction unit: results and functions.

Author

Ananth JV, Ban TA, Lehmann HE, and Rizvi FA

Subjects
Adult, Aged, Cardiovascular Diseases chemically induced, Edema chemically induced, Endocrine System Diseases chemically induced, Eye Diseases chemically induced, Female, Gastrointestinal Diseases chemically induced, Hematologic Diseases chemically induced, Humans, Male, Middle Aged, Movement Disorders chemically induced, Parasympatholytics adverse effects, Psychoses, Substance-Induced etiology, Skin Diseases chemically induced, Antidepressive Agents adverse effects, Phenothiazines adverse effects, Tranquilizing Agents adverse effects
Published
1971
Full Text
View/download PDF

32. Pimozide in the treatment of chronic schizophrenic patients.

Author

Chouinard G, Lehmann HE, and Ban TA

Subjects
Adult, Benperidol adverse effects, Clinical Trials as Topic, Female, Fluphenazine adverse effects, Fluphenazine therapeutic use, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Tranquilizing Agents adverse effects, Benperidol therapeutic use, Schizophrenia drug therapy, Tranquilizing Agents therapeutic use
Published
1970

34. Clinical studies with propericiazine (R.P. 8909).

Author

St Jean A, Sterlin C, Noe W, and Ban TA

Subjects
Acute Disease drug therapy, Adolescent, Adult, Aged, Association, Chlorpromazine administration & dosage, Chronic Disease drug therapy, Clinical Trials as Topic, Drug Synergism, Epilepsy complications, Female, Flicker Fusion drug effects, Humans, Imipramine administration & dosage, Injections, Intramuscular, Intellectual Disability drug therapy, Male, Methylphenidate administration & dosage, Middle Aged, Nicotinic Acids administration & dosage, Perphenazine administration & dosage, Phenobarbital administration & dosage, Phenothiazines adverse effects, Promethazine administration & dosage, Psychological Tests, Psychophysiology, Reaction Time drug effects, Schizophrenia drug therapy, Thioridazine administration & dosage, Tranylcypromine administration & dosage, Trifluoperazine administration & dosage, Behavior drug effects, Mental Disorders drug therapy, Phenothiazines administration & dosage, Tranquilizing Agents administration & dosage
Published
1967

35. A clinical study with propericiazine in chronic psychotic patients.

Author

Deutsch M, Ananth JV, and Ban TA

Subjects
Adult, Chronic Disease, Clinical Trials as Topic, Female, Humans, Male, Middle Aged, Phenothiazines administration & dosage, Phenothiazines adverse effects, Psychiatric Status Rating Scales, Thioridazine administration & dosage, Thioridazine adverse effects, Thioridazine therapeutic use, Nitriles therapeutic use, Phenothiazines therapeutic use, Piperidines therapeutic use, Psychotic Disorders drug therapy, Tranquilizing Agents therapeutic use
Published
1971

37. A new comparative physiognomy of neuroleptics: a collaborative clinical report.

Author

Bobon J, Bobon DP, Pinchard A, Collard J, Ban TA, De Buck R, Hippius H, Lambert PA, and Vinar O

Subjects
Antidepressive Agents classification, Antidepressive Agents pharmacology, Antidepressive Agents therapeutic use, Dose-Response Relationship, Drug, Humans, Mental Disorders drug therapy, Tranquilizing Agents classification, Tranquilizing Agents therapeutic use, Tranquilizing Agents pharmacology
Published
1972

Catalog

Books, media, physical & digital resources
See catalog results